These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18043005)

  • 1. Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E status.
    Rockwood K; Howlett S; Fisk J; Darvesh S; Tuokko H; Hogan DB; Wolfson C; McDowell I
    Neuroepidemiology; 2007; 29(3-4):201-7. PubMed ID: 18043005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.
    Dufouil C; Richard F; Fiévet N; Dartigues JF; Ritchie K; Tzourio C; Amouyel P; Alpérovitch A
    Neurology; 2005 May; 64(9):1531-8. PubMed ID: 15883313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of non-dementing cognitive disturbances and their association with vascular risk factors in an elderly population.
    Prencipe M; Santini M; Casini AR; Pezzella FR; Scaldaferri N; Culasso F
    J Neurol; 2003 Aug; 250(8):907-12. PubMed ID: 12928907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.
    Zandi PP; Sparks DL; Khachaturian AS; Tschanz J; Norton M; Steinberg M; Welsh-Bohmer KA; Breitner JC;
    Arch Gen Psychiatry; 2005 Feb; 62(2):217-24. PubMed ID: 15699299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation between APOE status and neuropsychological memory test performance: an analysis of the Canadian Study of Health and Aging.
    Klages J; Fisk JD
    Brain Cogn; 2002 Jul; 49(2):201-4. PubMed ID: 15259389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin use and the risk of incident dementia: the Cardiovascular Health Study.
    Rea TD; Breitner JC; Psaty BM; Fitzpatrick AL; Lopez OL; Newman AB; Hazzard WR; Zandi PP; Burke GL; Lyketsos CG; Bernick C; Kuller LH
    Arch Neurol; 2005 Jul; 62(7):1047-51. PubMed ID: 16009757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of APOE genotypes in a memory clinic cohort.
    van der Flier WM; Pijnenburg YA; Schoonenboom SN; Dik MG; Blankenstein MA; Scheltens P
    Dement Geriatr Cogn Disord; 2008; 25(5):433-8. PubMed ID: 18401171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of CIND by physical activity: different impact on VCI-ND compared with MCI.
    Middleton L; Kirkland S; Rockwood K
    J Neurol Sci; 2008 Jun; 269(1-2):80-4. PubMed ID: 18243244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Associations between dementia and head circumference as a measure of brain reserve--results from the Bavarian School sisters study].
    Bickel H; Riemenschneider M; Kurz A
    Psychiatr Prax; 2006 Apr; 33(3):138-44. PubMed ID: 16583352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment no dementia - neuropsychological and neuroimaging characterization of an amnestic subgroup.
    Jacova C; Peters KR; Beattie BL; Wong E; Riddehough A; Foti D; Scheltens P; Li DK; Feldman HH
    Dement Geriatr Cogn Disord; 2008; 25(3):238-47. PubMed ID: 18264009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is exposure to HMG-CoA reductase inhibitors (statins), fibrates, or other lipid-lowering drugs associated with reduced risk of bone fracture in older patients?
    Douglas LO
    J Fam Pract; 2000 Sep; 49(9):849-50. PubMed ID: 11032211
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents.
    Dupuy AM; Carrière I; Scali J; Cristol JP; Ritchie K; Dartigues JF; Gambert P; Ancelin ML
    Climacteric; 2008 Feb; 11(1):74-83. PubMed ID: 18202967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis.
    Ramcharan AS; Van Stralen KJ; Snoep JD; Mantel-Teeuwisse AK; Rosendaal FR; Doggen CJ
    J Thromb Haemost; 2009 Apr; 7(4):514-20. PubMed ID: 19036068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.
    Rockwood K; Kirkland S; Hogan DB; MacKnight C; Merry H; Verreault R; Wolfson C; McDowell I
    Arch Neurol; 2002 Feb; 59(2):223-7. PubMed ID: 11843693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
    Koro CE; Sowell MO; Stender M; Qizilbash N
    Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study.
    Gallacher J; Bayer A; Fish M; Pickering J; Pedro S; Dunstan F; Ebrahim S; Ben-Shlomo Y
    Psychosom Med; 2009 Jul; 71(6):659-66. PubMed ID: 19553290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and the risk of dementia.
    Jick H; Zornberg GL; Jick SS; Seshadri S; Drachman DA
    Lancet; 2000 Nov; 356(9242):1627-31. PubMed ID: 11089820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E genotypes in mild cognitive impairment subtypes.
    Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Paris F; Solfrizzi V; Dallapiccola B; Pilotto A
    J Am Geriatr Soc; 2006 Dec; 54(12):1965-6. PubMed ID: 17198524
    [No Abstract]   [Full Text] [Related]  

  • 19. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.
    Kurz MW; Dekomien G; Nilsen OB; Larsen JP; Aarsland D; Alves G
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):166-70. PubMed ID: 19321880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of cognitive impairment and dementia in the community: a 9-year-long prospective study.
    Caracciolo B; Palmer K; Monastero R; Winblad B; Bäckman L; Fratiglioni L
    Neurology; 2008 May; 70(19 Pt 2):1778-85. PubMed ID: 18184916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.